These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 6140045)
21. Inhibition of cyclic AMP accumulation by alpha 2-adrenoceptors in the rat cerebral cortex. Kuno N; Kamisaki Y; Itoh T Eur J Pharmacol; 1990 Feb; 176(3):281-7. PubMed ID: 1970302 [TBL] [Abstract][Full Text] [Related]
22. Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line. McCrea KE; Hill SJ Br J Pharmacol; 1993 Oct; 110(2):619-26. PubMed ID: 7902176 [TBL] [Abstract][Full Text] [Related]
23. Characterisation of human platelet adrenoceptors. Barnett DB; Swart SS; Nahorski SR; Cook N Adv Exp Med Biol; 1985; 192():97-108. PubMed ID: 2871708 [No Abstract] [Full Text] [Related]
24. Opposing functions of α- and β-adrenoceptors in the formation of processes by cultured astrocytes. Kitano T; Eguchi R; Okamatsu-Ogura Y; Yamaguchi S; Otsuguro KI J Pharmacol Sci; 2021 Mar; 145(3):228-240. PubMed ID: 33602503 [TBL] [Abstract][Full Text] [Related]
25. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Trochu JN; Leblais V; Rautureau Y; Bévérelli F; Le Marec H; Berdeaux A; Gauthier C Br J Pharmacol; 1999 Sep; 128(1):69-76. PubMed ID: 10498836 [TBL] [Abstract][Full Text] [Related]
26. Nitric oxide-dependent vasodilatation of rabbit femoral artery by beta(2)-adrenergic stimulation or cyclic AMP elevation in vivo. Xu B; Li J; Gao L; Ferro A Br J Pharmacol; 2000 Mar; 129(5):969-74. PubMed ID: 10696097 [TBL] [Abstract][Full Text] [Related]
27. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446 [TBL] [Abstract][Full Text] [Related]
28. Beta 3-adrenergic receptors are responsible for the adrenergic inhibition of insulin-stimulated glucose transport in rat adipocytes. Carpéné C; Chalaux E; Lizarbe M; Estrada A; Mora C; Palacin M; Zorzano A; Lafontan M; Testar X Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):99-105. PubMed ID: 7902704 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis. Whalen EJ; Bates JN; Johnson AK; Lewis SJ Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417 [TBL] [Abstract][Full Text] [Related]
30. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets. Clare KA; Scrutton MC; Thompson NT Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of rabbit intestine mediated by alpha- and beta-adrenoceptors. Bowman WC; Hall MT Br J Pharmacol; 1970 Feb; 38(2):399-415. PubMed ID: 4392102 [TBL] [Abstract][Full Text] [Related]
32. Relationship between lipolysis and cyclic AMP generation mediated by atypical beta-adrenoceptors in rat adipocytes. Hollenga C; Brouwer F; Zaagsma J Br J Pharmacol; 1991 Mar; 102(3):577-80. PubMed ID: 1364822 [TBL] [Abstract][Full Text] [Related]
33. Functional effects of long-term activation on human beta 2- and beta 3-adrenoceptor signalling. Nantel F; Bouvier M; Strosberg AD; Marullo S Br J Pharmacol; 1995 Mar; 114(5):1045-51. PubMed ID: 7780639 [TBL] [Abstract][Full Text] [Related]
34. Influence of adrenoceptor stimulation on aggregation of platelets from diabetic and control rats. Austin CE; Otter DJ; Chess-Williams R J Auton Pharmacol; 1995 Jun; 15(3):169-76. PubMed ID: 7673271 [TBL] [Abstract][Full Text] [Related]
35. Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in man. Jones CR; Giembcyz M; Hamilton CA; Rodger IW; Whyte K; Deighton N; Elliott HL; Reid JL Clin Sci (Lond); 1986 Feb; 70(2):147-53. PubMed ID: 2869850 [TBL] [Abstract][Full Text] [Related]
37. Increased interleukin-8 release by beta-adrenoceptor activation in human transformed bronchial epithelial cells. Lindén A Br J Pharmacol; 1996 Sep; 119(2):402-6. PubMed ID: 8886427 [TBL] [Abstract][Full Text] [Related]
38. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors. Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430 [TBL] [Abstract][Full Text] [Related]
40. The role of Gi proteins in reduced vasorelaxation response to beta-adrenoceptor agonists in rat aorta during maturation. Baloğlu E; Kiziltepe O; Gürdal H Eur J Pharmacol; 2007 Jun; 564(1-3):167-73. PubMed ID: 17395174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]